BX Swiss TOP 30 CHF
1.195,64
PKT
+10,32
PKT
+0,87
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.01.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
14.01.22 | Novartis Equal-weight | Morgan Stanley | |
13.01.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
13.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
12.01.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
12.01.22 | Holcim Buy | UBS AG | |
11.01.22 | UBS Sector Perform | RBC Capital Markets | |
11.01.22 | Richemont Overweight | Barclays Capital | |
11.01.22 | Roche Buy | Deutsche Bank AG | |
11.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
11.01.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
11.01.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
10.01.22 | Richemont Outperform | RBC Capital Markets | |
10.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
07.01.22 | UBS Neutral | UBS AG | |
07.01.22 | Novartis Neutral | UBS AG | |
07.01.22 | UBS Outperform | RBC Capital Markets | |
07.01.22 | UBS Sector Perform | RBC Capital Markets | |
06.01.22 | Richemont Buy | Goldman Sachs Group Inc. | |
06.01.22 | Zurich Insurance Hold | Deutsche Bank AG | |
06.01.22 | Swiss Re Hold | Deutsche Bank AG | |
06.01.22 | UBS Buy | Jefferies & Company Inc. | |
06.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
06.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
05.01.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
05.01.22 | Nestlé Underperform | Jefferies & Company Inc. | |
04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
04.01.22 | Roche Outperform | Bernstein Research | |
04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
23.12.21 | Holcim Buy | Goldman Sachs Group Inc. | |
23.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
17.12.21 | Holcim Buy | UBS AG | |
17.12.21 | Novartis Sell | Deutsche Bank AG | |
17.12.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |